Sister Company AMRIF readying up for clinical trial in chronic inflammatory disease

AMRIF, Alloksys’s sister company is readying up for trials in several chronic inflammatory disease applications. First of these are a study in RA patients, based on excellent results with hRESCAP in a first and only animal model for arthritides. Please see www.AMRIF.eu and publication Chandrupatla DMSH,et al 2018 Prophylactic and therapeutic activity of alkaline phosphatase in arthritic rats: single-agent effects of alkaline phosphatase and synergistic effects in combination with methotrexate.Transl Res. 2018 Sep;199:24-38. doi: 10.1016/j.trsl.2018.04.001. Epub 2018 May 17.

Close Menu